These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29222541)

  • 21. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
    Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
    Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality assurance and its impact on ovarian visualization rates in the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
    Sharma A; Burnell M; Gentry-Maharaj A; Campbell S; Amso NN; Seif MW; Fletcher G; Brunell C; Turner G; Rangar R; Ryan A; Jacobs I; Menon U
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):228-35. PubMed ID: 26095052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost-effectiveness of screening for oral cancer in primary care.
    Speight PM; Palmer S; Moles DR; Downer MC; Smith DH; Henriksson M; Augustovski F
    Health Technol Assess; 2006 Apr; 10(14):1-144, iii-iv. PubMed ID: 16707071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
    Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
    Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of transvaginal ultrasound in screening for ovarian cancer.
    Campbell S; Gentry-Maharaj A
    Climacteric; 2018 Jun; 21(3):221-226. PubMed ID: 29490504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.
    Menon U; Ryan A; Kalsi J; Gentry-Maharaj A; Dawnay A; Habib M; Apostolidou S; Singh N; Benjamin E; Burnell M; Davies S; Sharma A; Gunu R; Godfrey K; Lopes A; Oram D; Herod J; Williamson K; Seif MW; Jenkins H; Mould T; Woolas R; Murdoch JB; Dobbs S; Amso NN; Leeson S; Cruickshank D; Scott I; Fallowfield L; Widschwendter M; Reynolds K; McGuire A; Campbell S; Parmar M; Skates SJ; Jacobs I
    J Clin Oncol; 2015 Jun; 33(18):2062-71. PubMed ID: 25964255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
    Dilley J; Burnell M; Gentry-Maharaj A; Ryan A; Neophytou C; Apostolidou S; Karpinskyj C; Kalsi J; Mould T; Woolas R; Singh N; Widschwendter M; Fallowfield L; Campbell S; Skates SJ; McGuire A; Parmar M; Jacobs I; Menon U
    Gynecol Oncol; 2020 Aug; 158(2):316-322. PubMed ID: 32561125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population.
    Blyuss O; Burnell M; Ryan A; Gentry-Maharaj A; Mariño IP; Kalsi J; Manchanda R; Timms JF; Parmar M; Skates SJ; Jacobs I; Zaikin A; Menon U
    Clin Cancer Res; 2018 Oct; 24(19):4726-4733. PubMed ID: 30084833
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN; Ladabaum U
    Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness analysis of a multivariate index assay compared to modified American College of Obstetricians and Gynecologists criteria and CA-125 in the triage of women with adnexal masses.
    Forde GK; Hornberger J; Michalopoulos S; Bristow RE
    Curr Med Res Opin; 2016; 32(2):321-9. PubMed ID: 26588255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.
    Kumar V; Cohen JT; van Klaveren D; Soeteman DI; Wong JB; Neumann PJ; Kent DM
    Ann Intern Med; 2018 Feb; 168(3):161-169. PubMed ID: 29297005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of ovarian cancer screening on sexual activity and functioning: results from the UK collaborative trial of ovarian cancer screening RCT.
    Fallowfield L; Solis-Trapala I; Menon U; Langridge C; May S; Jacobs I; Jenkins V
    Br J Cancer; 2017 Apr; 116(8):1111-1117. PubMed ID: 28324886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.
    Ladabaum U; Mannalithara A; Brill JV; Levin Z; Bundorf KM
    Am J Gastroenterol; 2018 Dec; 113(12):1836-1847. PubMed ID: 29904156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian cancer screening-ultrasound; impact on ovarian cancer mortality.
    Kamal R; Hamed S; Mansour S; Mounir Y; Abdel Sallam S
    Br J Radiol; 2018 Oct; 91(1090):20170571. PubMed ID: 30102555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost-effectiveness analysis of a low-fat diet in the prevention of breast and ovarian cancer.
    Bós AM; Howard BV; Beresford SA; Urban N; Tinker LF; Waters H; Bós AJ; Chlebowski R; Ennis JM
    J Am Diet Assoc; 2011 Jan; 111(1):56-66. PubMed ID: 21185966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.
    Heijnsdijk EA; de Carvalho TM; Auvinen A; Zappa M; Nelen V; Kwiatkowski M; Villers A; Páez A; Moss SM; Tammela TL; Recker F; Denis L; Carlsson SV; Wever EM; Bangma CH; Schröder FH; Roobol MJ; Hugosson J; de Koning HJ
    J Natl Cancer Inst; 2015 Jan; 107(1):366. PubMed ID: 25505238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity.
    Saumoy M; Schneider Y; Shen N; Kahaleh M; Sharaiha RZ; Shah SC
    Gastroenterology; 2018 Sep; 155(3):648-660. PubMed ID: 29778607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
    Dilley J; Gentry-Maharaj A; Ryan A; Burnell M; Manchanda R; Kalsi J; Singh N; Woolas R; Sharma A; Williamson K; Mould T; Fallowfield L; Campbell S; Skates SJ; McGuire A; Parmar M; Jacobs I; Menon U
    Gynecol Oncol; 2023 Dec; 179():123-130. PubMed ID: 37980767
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.